Tong Ren Tang Sinopharm announced that the company recently received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration to allow the sale of “Three Child Family Granules [Tong Ren Tang]” in the Hong Kong Special Administrative Region. The registration number is HKC-18820. The certificate is valid until August 25, 2031. The main function of this product is to warm the lungs and relieve phlegm, lower gas and digestion, and is used for symptoms of phlegm congestion. As of the announcement date, the company has invested a total of about HK$800,000 in R&D of this product, which has not yet been put into market sales. Obtaining this certification will help enrich the company's product line and promote market expansion, and will not have a significant impact on the company's production, operation and performance.

Tong Ren Tang Sinopharm announced that the company recently received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration to allow the sale of “Three Child Family Granules [Tong Ren Tang]” in the Hong Kong Special Administrative Region. The registration number is HKC-18820. The certificate is valid until August 25, 2031. The main function of this product is to warm the lungs and relieve phlegm, lower gas and digestion, and is used for symptoms of phlegm congestion. As of the announcement date, the company has invested a total of about HK$800,000 in R&D of this product, which has not yet been put into market sales. Obtaining this certification will help enrich the company's product line and promote market expansion, and will not have a significant impact on the company's production, operation and performance.